IND Safety Reports: Industry Praises FDA’s Move Towards Less Unblinding, But Wants More Flexibility
Executive Summary
Sponsors are pleased with agency’s embrace of the ‘trigger’ approach to unblinding for safety reporting in new guidance but continue to want additional ways to keep the blind. Industry also raised concerns that parts of the guidance contradict international regulators.